Bibliography
- Cardonick E. Pregnancy-associated breast cancer: optimal treatment options. IJWH 2014;6:935-43
- Pavlidis NA. Co-existence of pregnancy and malignancy. Oncologist 2002;7:279-87
- Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol 2004;5:283-91
- Avilés A, Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2001;2:173-7
- Bastek JA, Sammel MD, Pare E, et al. Adverse neonatal outcomes: examining the risks between preterm, late preterm and term infants. Am J Obstet Gynecol 2008;199:367-8
- Avilés A, Diaz-Maqueo JC, Talvera A, et al. Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children. Am J Hematol 1991;36(4):243-8
- Hahn KM, Johnson PH, Gordon N, et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 2006;107:1219-926
- Amant F, von Minckwitz G, Han SN, et al. Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol 2013;31(20):2532-9
- Avilés A, Neri N, Nambo MJ. Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy. Ann Oncol 2006;17(2):286-8
- Van Calsteren K, Verbesselt R, Beijnen J, et al. Transplacental transfer of anthracyclines, vinblastine and 4-hydroxy-cyclophosphamide in a baboon model. Gynecol Oncol 2010;119(3):594-600
- Van Calsteren K, Verbesselt R, Devlieger R, et al. Transplacental transfer of paclitaxel, docetaxel, carboplatin and trastuzumab in a baboon model. Int J Gynecol Cancer 2010;20(9):1456-64
- Van Calsteren K. Chemotherapy during pregnancy: pharmacokinetics and impact on foetal neurological development. Facts Views Vis Obgyn 2010;2(4):278-86
- Van Hasselt JGC, van Calsteren K, Heyns L, et al. Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxel. Ann Oncol 2014;25:2059-65